Financing co-led by Ysios Capital and INKEF Capital, joined by Lundbeckfonden Ventures, LSP, and existing investors BioGeneration Ventures and InnovationQuarterProceeds to be used to achieve clinical proof of concept for lead compound, VMX-C001, advance program to...
Oss, The Netherlands, July 2, 2020 —Citryll announced it closed a total fundraise of € 18.5 million, led by Seventure(including their Health for Life Capital II fund), co-led by BioGeneration Ventures (BGV) with existing investors BOMBrabant Ventures, BrightGene and...
Amsterdam, The Netherlands, 1 July 2020 – Scenic Biotech BV (“Scenic”), a pioneer in the discovery of genetic modifiers to enable the development of disease modifying therapeutics for rare genetic disorders and other devastating illnesses, today announced that...
Investors include Bristol Myers Squibb, European Investment Fund, Industriens Pension, KfW Capital, Schroder Adveq Investment focus on entrepreneurial innovation in therapeutics in Europe Total assets under management >€220 million ($250m) Naarden, The...
Amsterdam, The Netherlands, 23 June 2020 – Scenic Biotech BV (“Scenic”), a pioneer in the discovery of genetic modifiers to enable the development of disease modifying therapeutics for rare genetic disorders and other devastating illnesses, today announced that...
Abdominal suturing tests show that the Switch® facilitates the use of ‘small-bites’ technique for sustainable abdominal wall closure, preventing incisional hernia Study in The Lancet[1] by investigators from Erasmus MC Rotterdam showing ‘small bites’ should become the...
